Colby Shad Thaxton
Fondateur chez Aurasense LLC
Profil
Colby Shad Thaxton is the founder of Aurasense LLC (founded in 2009) and Exicure Operating Co. (founded in 2011).
He holds the title of Vice President at Aurasense LLC.
He also founded Exicure, Inc. in 2011.
Dr. Thaxton's current jobs include being an Assistant Professor at Northwestern University, a Member at the International Institute For Nanotechnology, and a Member at the Institute for BioNanotechnology in Medicine.
Dr. Thaxton is also the founder of Zylem Biosciences, Inc.
Postes actifs de Colby Shad Thaxton
| Sociétés | Poste | Début |
|---|---|---|
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | Corporate Officer/Principal | - |
| International Institute For Nanotechnology | Corporate Officer/Principal | - |
Institute for BioNanotechnology in Medicine
 Institute for BioNanotechnology in Medicine Miscellaneous Commercial ServicesCommercial Services Institute for BioNanotechnology in Medicine promotes translational bionanotechology research that has the potential to revolutionize regenerative medicine and produce targeted therapeutics. It performs research in fields that can have profound impacts on regenerative medicine and targeted therapeutics, such as self-assembly, tissue engineering, genomics, smart drug delivery, and developing new bionanotechnologies. The company is headquartered in Chicago, IL. | Corporate Officer/Principal | - |
| Aurasense LLC | Fondateur | 01/12/2009 |
| Zylem Biosciences, Inc. | Fondateur | - |
Anciens postes connus de Colby Shad Thaxton
| Sociétés | Poste | Fin |
|---|---|---|
| EXICURE, INC. | Fondateur | 11/09/2019 |
Exicure Operating Co.
 Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | Fondateur | - |
Formation de Colby Shad Thaxton
| Northwestern University | Doctorate Degree |
| University of Colorado Boulder | Undergraduate Degree |
| Feinberg School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| EXICURE, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
| Aurasense LLC | |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | Health Technology |
Institute for BioNanotechnology in Medicine
Institute for BioNanotechnology in Medicine Miscellaneous Commercial ServicesCommercial Services Institute for BioNanotechnology in Medicine promotes translational bionanotechology research that has the potential to revolutionize regenerative medicine and produce targeted therapeutics. It performs research in fields that can have profound impacts on regenerative medicine and targeted therapeutics, such as self-assembly, tissue engineering, genomics, smart drug delivery, and developing new bionanotechnologies. The company is headquartered in Chicago, IL. | Commercial Services |
| Zylem Biosciences, Inc. | Health Technology |
